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NEW FINDINGS 
 What is the central question of this study?
Does modulating the expression of Klotho affect myogenesis following acute injury of 
healthy, non-senescent muscle. 
 What is the main finding and its importance?
Klotho can accelerate muscle growth following acute injury of healthy, adult mice, which 
supports the possibility that increased delivery of Klotho could have therapeutic value for 
improving repair of damaged muscle.  
ABSTRACT 
Skeletal muscle injuries activate a complex program of myogenesis that can restore normal 
muscle structure. We tested whether modulating the expression of klotho influenced the 
response of mouse muscles to acute injury. Our findings show that klotho expression in muscle 
declines at 3-days post-injury. That reduction in klotho expression coincided with elevated 
expression of targets of Wnt signaling (Ccnd1; Myc) and increased MyoD+ muscle cell numbers, 
reflecting the onset of myogenic cell differentiation. Klotho expression subsequently increased 
at 7-days post-injury with elevated expression occurring primarily in inflammatory lesions, 
which was accompanied by reduced expression of Wnt target genes (Ccnd1: 91%; Myc: 96%). 
Introduction of a klotho transgene maintained high levels of klotho expression over the course 
of muscle repair and attenuated the increases in Ccnd1 and Myc expression that occurred at 3-
days post-injury. Correspondingly, transgene expression reduced Wnt signaling in Pax7+ cells, 
reflected by reductions in Pax7+ cells expressing active β-catenin, and reduced the numbers of 
MyoD+ cells at 3-days post-injury. At 21-days post-injury, muscles in klotho transgenic mice 
showed increased Pax7+ and decreased myogenin+ cell densities and large increases in 
myofiber size. Likewise, treating myogenic cells in vitro with Klotho reduced Myod expression 
but did not affect Pax7 expression. Muscle inflammation was only slightly modulated by 
increased klotho expression, initially reducing the expression of M2-biased macrophage 
markers Cd163 and Cd206 at 3-days post-injury and later increasing the expression of pan-
macrophage marker F480 and Cd68 at 21-days post-injury. Collectively, our study shows that 
Klotho modulates myogenesis and that increased expression accelerates muscle growth after 
injury. 
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1. INTRODUCTION
The long-term ability of skeletal muscle to grow and respond to injury or disease largely 
depends on the numbers and functions of a population of myogenic stem cells, called satellite 
cells. In healthy, mature muscle, satellite cells reside in a quiescent state on the surface of 
fully-differentiated muscle fibers (Moss & Leblond, 1970). However, in response to muscle 
damage, they become rapidly activated, their populations expand and some daughter cells 
then undergo a complex program of differentiation that is necessary to establish and maintain 
normal muscle health and function (Dhawan & Rando, 2005; Lepper, Partridge, & Fan, 2011; 
Sambasivan et al., 2011; Seale et al., 2000). Perturbations of mechanisms that regulate 
satellite cell function can lead to loss of normal muscle function and, in some cases, reduce 
lifespan. 
Although numerous mechanisms interact to influence the response of satellite cells to muscle 
injury or disease and to determine their contributions to muscle growth and regeneration, 
recent discoveries have shown that the protein Klotho can play important roles in regulating 
the response of satellite cells to muscle disease (Wehling-Henricks et al., 2016, 2018). Klotho 
was originally identified as an anti-aging protein because mutations in the klotho gene cause 
changes in tissues that resemble accelerated aging (Kurosu et al., 2005). During our 
investigations into the pathophysiology of the progressive muscle wasting disease called 
Duchenne muscular dystrophy (DMD), we learned that klotho is epigenetically silenced in 
DMD muscle by increased methylation of lysine 9 on histone 3 (H3K9) in the promoter 
region of the klotho gene and by increased DNA methylation at CpG islands near the 
transcriptional start site of the klotho gene (Wehling-Henricks et al., 2016). We also 
demonstrated that genetic restoration of klotho to the mdx mouse model of DMD produced 
substantial reductions in muscle pathology and improved muscle regeneration (Wehling-
Henricks et al., 2016). Similarly, a subsequent study showed that the reduced expression of 
klotho in aging muscle may also contribute to defects in muscle regeneration that can be 
reversed by delivery of exogenous Klotho to old mice (Sahu et al., 2018). Thus, loss of 
normal levels of klotho expression in diseased or aged muscle is associated with impaired 
muscle regeneration that can be improved by interventions that increase Klotho delivery. 
However, whether increased delivery of Klotho can improve regeneration of muscle in which 
klotho expression has not been silenced by disease or age is unknown. 
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Many of the beneficial effects of Klotho on dystrophic muscle are attributable to its influence 
on satellite cells. Restoring klotho expression in dystrophic mice not only prevented the loss 
of satellite cells from dystrophic muscle at advanced stages of the mdx pathology, the 
transgene increased the number of satellite cells per muscle fiber as the disease progressed 
and the mice aged (Wehling-Henricks et al., 2016). Those increases were also associated with 
increased muscle fiber size and reduced fibrosis (Wehling-Henricks et al., 2016). At least 
some of these effects were attributable to direct actions on proliferative satellite cells and on 
post-mitotic, myogenic cells called myotubes that are formed by fusion of activated satellite 
cells into multinucleated precursors of muscle fibers. When satellite cells in vitro were 
stimulated with exogenous Klotho in the presence of co-factors, satellite cell proliferation 
increased and when myotubes were similarly stimulated, they shifted to a more positive 
protein balance (Wehling-Henricks et al., 2016). In addition, age-related reductions in 
satellite cell mitochondrial function were reduced by treatment with Klotho in vitro, which 
may also contribute to Klotho-mediated improvements in function (Sahu et al., 2018). 
Klotho can be expressed as a transmembrane protein (m-Klotho) or as an alternatively spliced 
isoform that can be secreted (s-Klotho) (Kuro-o et al., 2005; Li et al., 2004; Matsumura et al., 
1998). The extracellular domain of m-Klotho can also be cleaved and released, adding to 
extracellular s-Klotho (Chen et al., 2007; Imura et al., 2004) which functions as a hormone 
(Saito et al., 2000). S-Klotho’s actions on target cells can be influenced by the presence of 
FGF23 (Wehling-Henricks et al., 2016) or it can act independent of FGF23 signaling (Xie et 
al., 2015) through mechanisms that are not yet well understood (Dalton et al., 2017). 
However, the pro-proliferative and anabolic effects of Klotho on myogenic cells are 
enhanced by the presence of FGF23, at least in vitro (Wehling-Henricks et al., 2016).  
Several pathways that are important in regulating myogenesis are influenced by s-Klotho in 
non-muscle tissues (Doi et al., 2011; Kuro-o et al., 1997; Liu et al., 2007), which suggests 
they are potential targets for s-Klotho in skeletal muscle, as well. For example, Klotho can 
bind to Wnt1, Wnt3a, Wnt4, Wnt5a and Wnt7a (Liu et al., 2007; Zhou et al., 2013)
 
and that 
binding is sufficient to inhibit activity of at least Wnt3a in a cell free system (Leung et al., 
2002). Furthermore, Klotho treatment of muscle cells in vitro diminished Wnt signaling, 
which was attributed to Klotho binding to extracellular Wnt (Ahrens et al., 2018). Those in 
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vitro observations suggest that if Klotho also modifies Wnt signaling in growing or 
regenerating muscle in vivo, myogenesis could be affected because signaling through the 
canonical, β-catenin-dependent Wnt pathway increases satellite cell differentiation (Brack et 
al., 2008; Han et al., 2011; Polesskaya, Seale, & Rudnicki, 2003; Rochat et al., 2004). Thus, 
the expansion of satellite cell numbers in the presence of elevated levels of Klotho in vivo or 
in vitro (Wehling-Henricks et al., 2016) may reflect a slowing of muscle differentiation 
caused by Klotho inhibition of Wnt because terminal differentiation of satellite cells and their 
progeny entails permanent withdrawal from the cell cycle. 
Although Klotho can modulate myogenesis in diseased or injured tissue by direct actions on 
satellite cells, it may also play indirect roles by influencing inflammatory cell populations 
that regulate muscle growth. In particular, macrophages play a central role in regulating 
muscle growth and regeneration following injury (Tidball, 2017) and the expression of 
cytokines that determine macrophage function is influenced by Klotho. For example, 
increases in Klotho can reduce expression of tumor necrosis factor (TNF) (Hui et al., 2017) 
and TNF-stimulation of macrophages in the presence of interferon-gamma (IFN) induces a 
pro-inflammatory phenotype (M1-biased phenotype) that can increase muscle damage or 
increase myoblast proliferation (Bencze et al., 2012; Villalta et al., 2009).  Klotho treatments 
can also increase expression of interleukin-10 (IL10) by macrophages (Wehling-Henricks et 
al., 2018), which deactivates the M1 biased phenotype and induces an anti-inflammatory M2 
macrophage phenotype that can increase muscle growth and regeneration following injury 
(Deng et al., 2012). 
In this investigation, we test whether increasing Klotho delivery to non-diseased, non-
senescent muscles by expressing a klotho transgene improves muscle growth and 
regeneration following acute injury. We also assay whether elevations in Klotho influence the 
numbers or differentiation of satellite cells in regenerative muscle and whether the changes in 
myogenesis are reflected by changes in signaling through the canonical Wnt pathway or by 
modifications in the inflammatory response to muscle injury. Collectively, the findings 
indicate that modulation of Klotho expression in injured muscle can significantly affect 
growth following acute muscle injury, providing a potential mechanism for influencing the 
rate of muscle repair in vivo. 
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2. METHODS
2.1  Ethical approval 
All animals were handled according to guidelines provided by the Chancellor’s Animal 
Research Committee at the University of California, Los Angeles (Animal Welfare 
Assurance number A-3196).  The investigation complied with the principles and standards 
for reporting animal experiments (Grundy, 2015). 
2.2  Animals 
C57BL/6 (wild-type) mice were purchased from The Jackson Laboratory (Bar Harbor, ME) 
and bred in specific pathogen-free vivaria at the University of California, Los Angeles. The 
production of transgenic mice that over-express klotho (EFmKL46) has been described 
previously (Kuro-o et al., 1997). The klotho transgene is under control of the elongation 
factor 1α promoter that causes systemic expression of the transcript and approximately 
doubles circulating Klotho levels (Kurosu et al., 2005). Mice carrying the klotho transgene 
were crossed onto the C57BL/6 background for a minimum of six generations. Mice were 
housed on a 12/12 hour light/dark cycle and were provided food and water ad libitum. 
Following euthanasia by inhalation of isoflurane, muscles were collected, weighed and flash-
frozen for subsequent sectioning and histological evaluation or used for RNA isolation. 
Experimental group size ranged from 5-8 mice per group (48 total mice).  
2.3  Acute muscle injury 
Mice were briefly anesthetized with isoflurane inhalation in a chamber (4-5% isoflurane with 
pure oxygen for induction) then moved to a nose cone (1-2% isoflurane). Anesthesia was 
checked by testing mice for a positive reflex response to a hind foot pinch and by monitoring 
respiration. The lower limb was wiped with 70% ethanol before intramuscular injection. 
Sterile muscle injury was induced by the intramuscular injection of 50 μl of a 1.2% barium 
chloride (BaCl2) solution into the midbelly of tibialis anterior (TA) muscles of healthy, 5-
month old adult male wild-type and klotho transgenic mice. Animals were monitored daily 
until they recovered. 
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2.4  RNA isolation and QPCR 
RNA was isolated from muscle homogenates and electrophoresed on agarose gels and its 
quality assessed by 28S and 18S ribosomal RNA integrity (Wehling-Henricks et al., 2016). 
RNA samples (2 μg) were reverse transcribed with Super Script Reverse Transcriptase II 
using oligo dTs to prime extension (Invitrogen) to produce cDNA. Expression of selected 
transcripts was assayed using SYBR green qPCR Supermix according to the manufacturer’s 
protocol (BioRad) and an iCycler thermocycler system equipped with iQ5 optical system 
software (BioRad). Established guidelines for experimental design, data normalization and 
data analysis for QPCR were used to maximize the rigor of quantifying the relative levels of 
mRNA (Bustin et al., 2009; Nolan, Hands, & Bustin, 2006). We empirically tested up to 20 
reference genes and identified those with the least variability between experimental groups. 
Based on that analysis, the relative expression of transcripts of interest were normalized to 
the reference genes Srp14 and Hagh for muscle regeneration QPCR assays. The 
normalization factor for each sample was calculated by geometric averaging of the Ct values 
of reference genes. Expression for each gene in control samples was set to 1 and the other 
values were scaled to the control. Primers used for QPCR are listed in Table 1. Primers for 
klotho were designed to a cDNA sequence that is present in both m-klotho and s-klotho. 
Primers for s-klotho were designed so that the downstream primer binds a region of the 
cDNA sequence that is absent from full-length m-klotho (Shiraki-Iida et al., 1998). 
2.5  Muscle fiber cross-sectional area 
Frozen TA muscles were cross-sectioned at the midbelly and used for fiber cross-sectional 
area measurements. Sections were stained with hematoxylin and the cross-sectional areas of 
fibers were measured using a digital imaging system (Bioquant). In muscle that had 
undergone acute injury, only centrally-nucleated, regenerating muscle fibers (Chargé & 
Rudnicki, 2004) were measured from the area of the central lesion, identified as the region 
that was least regenerated, as previously described (Miller et al., 2000). The classification of 
small and large fibers was determined by setting three standard deviations from the mean 
cross-sectional area for the wild-type group at both the 7- and 21-days post-injury time points 
and quantifying the proportion of myofibers measured that fell within these ranges, adapted 
from (White et al., 2009). At 7-days post-injury, fibers were considered small or large if less 
than 623 μm
2
 or greater than 1603 μm
2
, respectively. The threshold for small and large fibers 
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at 21-days post-injury was determined to be less than 458 μm
2




2.6  Production of Pax7 antibody 
Pax7 hybridoma cells were purchased from Developmental Studies Hybridoma Bank (Iowa 
City, Iowa). Cells were cultured and antibody was isolated from the supernatant as previously 
described (Wehling-Henricks et al., 2016). 
2.7  Immunohistochemistry 
We assayed for relationships between the distribution of Pax7+ cells, macrophages and 
Klotho by performing immunohistochemistry on serial sections obtained from injured 
muscles. Double- or triple-immunolabeling was not performed because each of the antigens 
that we probed required different fixation protocols to retain their ability to bind the primary 
antibodies used in the investigation. Muscles were dissected from euthanized mice and then 
rapidly frozen in liquid nitrogen-cooled isopentane. For identification of Pax7+ cells, 10-µm-
thick cross-sections were taken from the mid-belly of muscles, air-dried for 30 min and then 
fixed in 4% paraformaldehyde for 10 minutes. Sections were then immersed in antigen 
retrieval buffer (10 mM sodium citrate, 0.05% Tween 20, pH 6.0) at 95–100°C for 40 
minutes. Endogenous peroxidase activity in the tissue was quenched by immersion in 0.3% 
H2O2. Sections were then treated with blocking buffer from a mouse-on-mouse 
immunohistochemistry kit (M.O.M kit; Vector) for 1 hour and immunolabeled with affinity 
purified mouse anti-Pax7 (1:500) overnight at 4°C. Sections were washed with phosphate 
buffered saline solution (PBS) and then incubated with biotin-conjugated anti-mouse IgG 
(1:250) for 30 minutes. Sections were subsequently washed with PBS and then incubated for 
30 minutes with ABC reagents from the M.O.M kit. Staining was visualized with the 
peroxidase substrate 3-amino-9-ethylcarbazole (AEC; Vector), yielding a red reaction 
product. 
Macrophages were identified in adjacent sections that were fixed in ice-cold acetone and 
endogenous peroxidase activity was quenched, followed by incubation for 1 hour with 
blocking buffer (3% bovine serum albumin (BSA), 2% gelatin and 0.05% Tween-20 in 50 
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mM Tris-HCl pH 7.6 containing 150 mM NaCl). Sections were then incubated with rat anti-
mouse CD206 (1:50, 3 hours at RT, AbD Serotec, clone MR5D3; RRID:AB_324622). The 
sections were washed with PBS and probed with biotin-conjugated secondary antibodies 
(1:200; 30 minutes at RT, Vector Laboratories). Sections were then washed with PBS and 
incubated with avidin D-conjugated HRP (1:1000; 30 minutes at RT, Vector) and staining 
was visualized with AEC. Immunohistochemistry for Klotho was performed similarly on 
serial sections, except the sections were fixed in 4% paraformaldehyde for 10 minutes, no 
antigen retrieval was performed and the primary antibody (rat anti-mouse Klotho; R&D 
Systems #MAB1819, clone 236214; RRID:AB_2131926) was applied overnight at 4
o
C. 
In other immunohistochemical assays to assess numbers of myogenic cells at later stages of 
myogenesis, sections were prepared identically to the Pax7 labeling protocol, except mouse 
anti-MyoD (1:50) (BD Pharmingen #554130; RRID:AB_395255) or mouse anti-myogenin 
(1:50) (BD Pharmingen #556358; RRID:AB_396383) were used as primary antibodies. 
2.8  Immunofluorescence 
The double-staining protocol for Pax7 and activated β-catenin was similar to the anti-Pax7 
method described above, although the anti-Pax7 antibody was applied to sections together 
with rabbit anti-non-phosphorylated (active) β-catenin (serine 45) (1:1600) (Cell Signaling 
Technology #19807T; RRID:AB2650576) for overnight incubation at 4°C. Sections were 
subsequently incubated with a combination of Dylight 488 anti-rabbit IgG and Dylight 594 
anti-mouse IgG (Vector). Wnt signaling in satellite cells was determined by quantifying the 
percentage of satellite cells (Pax7+) that expressed active β-catenin (β-catenin+/ Pax7+ cells). 
The double-staining protocol for Pax7 and Ki67 was identical to the Pax7/ β-catenin protocol 
except that anti-β-catenin was replaced by goat anti-Ki67 (1:200) (Santa Cruz Biotech. 
#sc7846) and anti-rabbit IgG was replaced by biotinylated anti-goat IgG (1:200; Vector) 
followed by streptavidin 488 (1:500; Vector). 
2.9  Quantification of cell numbers 
Numbers of Pax7+, MyoD+ and myogenin+ cells per unit volume of muscle were determined 
by counting the numbers of antibody-labeled cells per unit area in entire cross-sections of 
muscles. Muscle cross-sectional area in each section was determined by using a sterological 
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point-counting technique and muscle volume in each section was determined by multiplying 
the area of the sectioned muscle by the section thickness (10 m). 
2.10  Klotho stimulation of myoblasts in vitro 
Myoblasts (C2C12; ATCC; Manassas, VA, USA; RRID:CVCL_0188) were seeded in 6 cm 
dishes at 1.2 x 10
5




) and maintained in complete medium 
(Dulbecco’s modified Eagle media (DMEM) containing 10% fetal bovine serum (FBS), 100 
U/ml penicillin and 100 µg/ml streptomycin) at 37°C and 5% CO2.  Attached cells were 
approximately 30% confluent 24 hours after plating. The myoblasts were stimulated with 
either heparin only (Hep; 10 µg/ml), Klotho + heparin (KL/Hep; 1 µg/ml KL; (R&D 
Systems, Minneapolis, MN)), recombinant fibroblast growth factor-23 (FGF/Hep; 0.5 µg/ml 
FGF-23; (R&D Systems)), or Klotho, FGF-23 and heparin (KL/FGF/Hep) in fresh medium at 
24 and 48-hours post-plating. Five technical-replicate plates were stimulated per treatment 
condition. Myoblasts were approximately 90% confluent and not fused when they were 
collected 24 hours following the second stimulation. The cells were then washed twice with 
PBS and collected in Trizol. RNA was extracted and isolated with chloroform extraction and 
isopropyl alcohol precipitation followed by clean up using RNAeasy spin columns (Qiagen) 
and concentrator kit (Zymo Research). Total RNA was reverse transcribed and used for 
qPCR.  Eff1a1 and Srp14 were used as reference genes. 
2.11  Klotho stimulation of myotubes in vitro 
C2C12 myoblasts were cultured as described above. When the cells reached confluence, they 
were transferred to differentiation medium (DMEM with 100 U/ml penicillin, 100 µg/ml 
streptomycin) overnight to induce differentiation and fusion to form myotubes. The cells 
were then stimulated with either heparin only (10 µg/ml), Klotho (1 µg/ml) + heparin, FGF-
23 (0.5 µg/ml) + heparin, or Klotho, FGF-23 and heparin in complete medium at 24 and 48 
hours post-differentiation. Five technical-replicate wells were stimulated per treatment 
condition. After treatment, the myotubes were used for RNA isolation and QPCR, as 
described above. 
2.12  Statistical methods  
All data are presented as mean ± standard deviation. Prior to analysis, statistical outliers were 
identified using Grubbs’ outlier test (P < 0.05). Statistical significance was calculated using 
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unpaired Student’s t-tests or ordinary one-way ANOVA with Tukey’s multiple comparison 
test to determine differences among multiple groups. Differences with a p value < 0.05 were 
considered statistically significant. Statistical analysis was performed using GraphPad Prism. 
3  RESULTS 
3.1  Klotho expression is influenced by acute muscle injury   
Previous investigations have shown that the onset of muscle damage and inflammation in 
mdx muscular dystrophy produces a drastic down-regulation of klotho expression that persists 
for the lifetime of the affected mice and exacerbates muscle pathology (Wehling-Henricks et 
al., 2016; 2018). We assayed whether muscle damage and inflammation caused by acute 
injury were also associated with persistent down-regulation of muscle klotho expression that 
could have long-term influences on muscle health. Similar to mdx muscles at the onset of 
pathology, we observed that klotho gene expression was reduced by ~69% at 3-days 
following muscle injury by BaCl2 injection (Figure 1A). In contrast to mdx muscle, the 
diminished expression of klotho was only transient in acutely injured muscle. At 7-days post-
injury, klotho expression in muscle increased by 385% compared to 3-days post-injury and 
exceeded expression levels that occurred in non-injured controls. Klotho expression 
subsequently returned to control levels at 21-days post-injury (Figure 1A). However, 
expression of s-klotho did not decline at 3-days post-injury, but increased by 374% at 7-days 
post-injury, compared to uninjured controls (Figure 1B). Furthermore, immunohistochemistry 
using antibodies that recognized both m-Klotho and s-Klotho showed that inflammatory 
lesions enriched in CD206+ macrophages contained the highest Klotho concentration where 
it was detectible both within cells in the inflammatory lesions and in the extracellular space 
(Figures 1D, E). Few Pax7+ cells were identified in the inflammatory lesions (Figure 1F). We 
also observed no detectible Klotho in muscle fibers in injured muscle (Figure 1D) which is 
consistent with previous findings that klotho expression is silenced in inflamed, dystrophic 
muscle although expression in CD206+ macrophages in inflammatory lesions in muscle 
persists (Wehling-Henricks et al., 2016; 2018). 
3.2  Klotho promotes muscle growth after acute injury 
The recent finding that defects in repair and regeneration of mdx muscles can be corrected by 
increased delivery of Klotho to the diseased muscle by expression of a klotho transgene 
(Wehling-Henricks et al., 2016; 2018) suggested that increased Klotho in acutely injured 
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muscle could also improve growth and regeneration. We tested that possibility by assaying 
muscle fiber growth during repair following BaCl2-mediated injury of wild-type and klotho 
transgenic mice. First, we established that expression of the klotho transgene was elevated 
over the entire course of muscle regeneration under investigation (Figure 2A). Because our 
previous studies showed that Klotho-induced increases in myogenic cell proliferation and 
myotube growth were enhanced by FGF23, we also confirmed that FGF23 expression 
occurred in non-injured muscles and that its expression was not significantly influenced by 
injury or by expression of the klotho transgene (Figures 1C and 2B).   
Measurements of muscle fiber cross-sectional areas were used to assay for effects of the 
transgene on muscle growth and regeneration.  All fibers in areas of the central lesion were 
assayed and the number of injured fibers measured per muscle ranged from 101 to 280. 
Although transgene expression caused reductions in mass of non-injured TA muscles and 
reductions in TA mass normalized to body mass (Figures 3A-C), the transgene did not affect 
TA muscle fiber size in non-injured muscles (p = 0.82; two-tailed T-test) (Figures 3D-F). 
Muscle fiber cross-sectional areas of klotho transgenic and wild-type TA muscles also did not 
differ at 7-days post-injury (p = 0.19; two-tailed T-test) (Figures 4A-D). However, at 21-days 
post-injury, fiber cross-sectional areas of klotho transgenic mice returned to the size of non-
injured muscles and were significantly larger than fiber cross-sectional areas of wild-type 
mice (Figures 4E-H). Furthermore, although klotho transgenic muscle fibers experienced a 
significant 139% increase in fiber cross-sectional area between 7- and 21-days post-injury, 
wild-type mice showed only a 60% increase in fiber size during the same period of muscle 
repair (Figures 4C, G). 
3.3  Klotho modulates myogenesis following acute muscle injury 
The activation, proliferation and differentiation of satellite cells and myogenic progenitor 
cells (MPCs) that are derived from satellite cells are essential for normal, successful repair of 
muscle following injury (Fry et al., 2015). We assayed for the numbers of quiescent or 
recently activated satellite cells (Pax7+ cells), the numbers of activated satellite cells at early 
stages of differentiation (MyoD+ cells) and the numbers of satellite cell progeny that were 
committed to terminal differentiation (myogenin+ cells). Numbers of myogenic cells 
expressing any of the three developmental markers did not differ between wild-type and 
klotho transgenic mice in non-injured muscles (Pax7: p = 0.89; MyoD: p = 0.56; myogenin: p 
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= 0.30) (Figures 5A, D, G). Three days after injury, the number of Pax7+ cells per unit 
volume was similar in wild-type and klotho transgenic muscle (p = 0.87; two-tailed T-test). 
However, at 7- and 21-days post-injury, the number of Pax7+ cells per unit volume was 55% 
greater in TA muscles of klotho transgenic mice compared to wild-type mice (Figures 5A-C). 
In addition, individual muscle fibers in transgenic mice were frequently identified with 
multiple Pax7+ cells in a single plane of section, suggesting multiple rounds of division of 
individual satellite cells undergoing clonal expansion on the surface of injured, transgenic 
muscle fibers (Figure 5C).  However, the proportion of Pax7+ cells that were Ki67+ did not 
differ significantly between wild-type vs. transgenic muscles at 7-days post-injury (wild-type: 
2.25%, standard deviation = 0.55, n = 5; klotho transgenic: 1.83%, standard deviation = 0.98, 
n = 4; p = 0.42; two-tailed T-test). That observation suggests that there are more cycling 
satellite cells in the transgenic muscles, reflecting the increased number of total Pax7+ 
satellite cells in those muscles, although the proportion of the total population in the cell 
cycle did not differ. 
At 3-days post-injury, MyoD+ cells in injured muscle increased tremendously in both klotho 
transgenic and wild-type mice, although the population was nearly 70% greater in wild-type 
muscles (Figure 5D). However, in the interval between 3- and 7-days post-injury, MyoD+ 
cell numbers did not change in wild-type muscles (p = 0.33; two-tailed T-test), but MyoD+ 
cell numbers in klotho transgenic muscles increased by ~212% during the same interval 
(Figure 5D).  By 21-days post-injury, MyoD+ cell numbers nearly returned to levels that 
occur in uninjured muscles, and did not differ significantly between wild-type and klotho 
transgenic mice (Figures 5D-F).   
Numbers of myogenin+ cells in muscles did not differ between wild-type and klotho 
transgenic mice at 3-days post-injury (p = 0.65; two-tailed T-test) (Figure 5G). At 7-days 
post-injury, the numbers of myogenin+ cells increased greatly in both wild-type mice and 
klotho transgenic mice, with the increase in klotho transgenic mice exceeding numbers in 
wild-type mice by ~80% (Figure 5G).  At 21-days post-injury, numbers of myogenin+ cells 
nearly returned to levels that occurred in non-injured TA muscles for both wild-type and 
klotho transgenic mice, although there were significantly fewer myogenin+ cells in klotho 
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3.4  Klotho can affect MPC populations by affecting expression of myogenic 
transcription factors 
Because changes in numbers of Pax7+, MyoD+ and myogenin+ cells in injured muscle in 
vivo could reflect direct or indirect influences of Klotho on muscle cells, we assayed whether 
direct stimulation of myoblasts or myotubes with Klotho and its co-factors FGF-23 and 
heparin in vitro influenced expression of those myogenic transcription factors. We found that 
stimulation of either myoblasts or myotubes with Klotho alone had no influence on Pax7 
expression (myoblasts: p = 0.23; myotubes: p = 0.78) or myogenin expression (myoblasts: p 
= 0.55; myotubes: p = 0.94), although FGF23 without Klotho reduced expression of both 
transcription factors (Figures 6A, C, D, F). However, expression of MyoD in myoblasts or 
myotubes was diminished by Klotho stimulation, if FGF23 were also present, although 
FGF23 alone had no effect on MyoD expression (myoblasts: p = 1.00; myotubes: p = 0.06),  
(Figures 6B, E). Because previous findings showed that stimulation of myoblasts with Klotho 
and co-factors significantly increases cell proliferation (Wehling-Henricks et al., 2016), these 
observations suggest that the expansion of Pax7+ cells in muscle following injury reflects an 
increase in cell proliferation and not a direct influence on the expression of Pax7 by 
myogenic cells. However, the reduction in MyoD+ cells in injured muscles of klotho 
transgenic mice at 3-days post-injury could reflect a direct, negative influence of Klotho on 
MyoD expression. 
 
3.5  Klotho modulates Wnt signaling in satellite cells after injury 
Our findings concerning the effects of klotho transgene expression on the course of 
myogenesis during muscle repair following injury suggest that muscle is influenced by 
changes in Klotho levels at early stages of MPC differentiation, which can influence the rate 
of muscle fiber growth during later stages of regeneration. Because the onset of MPC 
differentiation in postnatal myogenesis after injury is driven, at least in part, by Wnt-
signaling (Brack et al., 2008) and Klotho is a Wnt antagonist (Liu et al., 2007), we tested 
whether klotho transgene expression affects Wnt-signaling in muscle. We assayed for 
changes in the expression of Wnt target genes Axin2 (Figure 7A), Ccnd1 (Figure 7B) and 
Myc (Figure 7C) as indices of Wnt-signaling. At 3-days post-injury Axin2, Ccnd1 and Myc 
were significantly reduced in klotho transgenic mice compared to wild-type. Surprisingly, 
klotho transgenic mice showed increased Myc gene expression in uninjured muscle (Figure 
7C) and increased Ccnd1 gene expression in muscle at 21-days post-injury, compared to 
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wild-type (Figure 7B). Because our findings showed a consensus reduction in the expression 
of Wnt-target genes at 3-days post-injury and because most MPCs signal through the 
canonical Wnt pathway at day 2 through day 5 after injury (Brack et al., 2008), we focused 
on the 3-day post-injury time point. We assessed Wnt activation in satellite cells using a non-
phosphorylated β-catenin antibody that detects functionally active β-catenin that mediates 
canonical Wnt-signaling (Cadigan & Nusse, 1997; Sakanaka, 2002) and found that the 
proportion of Pax7+ cells expressing active β-catenin was reduced in klotho transgenic 
muscle 3-days post-injury relative to wild-type (Figures 7D-L). These data indicate that 
Klotho modulates Wnt-signaling in muscle after injury. 
3.6  Klotho modulates the inflammatory response after acute muscle injury 
The inflammatory response to muscle injury can have major effects on determining the 
success or failure of muscle regeneration (Tidball, 2017) and our previous work has 
demonstrated that Klotho can influence cytokine production by macrophages (Wehling-
Henricks et al., 2018). In particular, we found that Klotho and FGF23 stimulation can act 
directly on macrophages to affect TNFα and IL-10 secretion, important regulators of 
macrophage phenotype in muscle (Wehling-Henricks et al., 2018). Furthermore, the 
expression of a klotho transgene in mdx mice modifies macrophage phenotype in dystrophic 
muscle (Wehling-Henricks et al., 2016; 2018). Our QPCR analysis of wild-type and klotho-
transgenic, uninjured muscle showed that Klotho does not affect expression of transcripts for 
the pan-macrophage marker F4/80 (p = 0.12; two-tailed T-test), the M1-biased macrophage 
marker CD68 (p = 0.84) or the M2-biased macrophage markers CD163 (p = 0.30) and CD206 
(p = 0.75) (Figures 8A-D). However, transcripts for macrophage markers were affected by 
Klotho following muscle injury. Three days post-injury, Klotho caused small, but significant, 
reductions in the expression of Cd163 (Figure 8C) and Cd206 (Figure 8D). The expression of 
F4/80 (Figure 8A), Cd68 (Figure 8B) and Cd206 (Figure 8D) experienced small increases in 
expression in muscle 21-days post-injury in klotho transgenic mice. Increased F4/80 
expression suggests that Klotho may prolong macrophage accumulation in muscle after acute 
injury, while increased Cd68 and Cd206 expression indicates increases in both M1 and M2-
biased macrophages. Our findings of prolonged or increased inflammation are further 
supported by QPCR showing increased Tnf (Fig. 8E) and Il10 (Fig. 8F) gene expression 21-
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4  DISCUSSION 
 
The current investigation shows that modulating klotho expression influences muscle growth 
that follows acute injuries in healthy, adult mice and suggests that systemic elevation of 
klotho expression can accelerate muscle repair. Several observations indicate that at least 
some of these effects of Klotho on muscle repair are mediated during early stages of muscle 
regeneration by Klotho antagonism of Wnt signaling. As shown by other investigators, 
Klotho binds to several members of the Wnt family (Liu et al., 2007; Zhou et al., 2013) and 
that binding to Klotho can inhibit activity of at least Wnt3a (Liu et al., 2007). In addition, 
Klotho treatment of single, isolated muscle fibers in vitro diminished Wnt signaling, which 
was attributed to Klotho binding to extracellular Wnt (Ahrens et al., 2018). In the present 
study, we found that at 3-days post-injury in wild-type muscle, a significant reduction of 
klotho expression in muscle was accompanied by elevations in the expression of downstream 
targets of Wnt signaling (Ccnd1 and Myc), and those events coincided with large increases in 
numbers of MyoD+ MPCs, reflecting the initiation of satellite cell differentiation. At 7-days 
post-injury, klotho expression in wild-type muscle increased 3.9-fold over levels occurring in 
muscle at 3-days post-injury, which was accompanied by large reductions in expression of 
Wnt target genes (Ccnd1: 91%; Myc: 96%), and abrogation of further increases in MyoD+ 
cell numbers. However, expression of a klotho transgene which prevented the reduction in 
klotho expression that normally occurred in muscles at 3-days post-injury attenuated the 
increase in Ccnd1 and Myc expression that occurred at that stage in wild-type mice, and 
diminished numbers of MyoD+ cells by more than half. These observations show that early 
stages of muscle regeneration following acute injury are affected by changes in klotho 
expression. 
 
Our finding that expression of the klotho transgene reduced the proportion of Pax7+ cells that 
express β-catenin at 3-days post-injury shows that satellite cells may be targets for Klotho 
inhibition of Wnt signaling in injured muscle in vivo. That observation also suggests a 
potential mechanism for the Klotho-induced reduction of MyoD expression at 3-days post-
injury. β-catenin is an obligatory, downstream effector in the canonical Wnt signaling 
pathway that can bind and activate MyoD, a basic helix-loop-helix myogenic transcription 
factor that must be expressed for successful muscle regeneration to occur (Cadigan & Nusse, 
1997; Kim et al., 2008; Megeney et al., 1996). Normally after injury, MPCs undergo a period 
This article is protected by copyright. All rights reserved. 
18 
of proliferation followed by activation of MyoD expression and the onset of muscle 
differentiation that is induced by Wnt signaling (Brack et al., 2008). Thus, our in vivo data 
suggest that the transient reduction of klotho expression that occurred in wild-type muscles at 
3-days post-injury could contribute to a transient increase in Wnt signaling in satellite cells.
In turn, that elevation of Wnt signaling could lead to increases in MyoD expressing MPCs, 
thereby promoting muscle differentiation. However, Klotho-mediated reductions in numbers 
of MyoD+ cells could also occur through pathways independent of Wnt signaling. Our in 
vitro data show that direct stimulation of myoblasts and myotubes with Klotho reduces 
MyoD expression, in the absence of exogenous Wnt stimulation.  
Our finding that expression of endogenous klotho is significantly reduced in muscle at 3-days 
following injury with BaCl2, after which its expression increases above baseline levels at 7-
days post-injury, supports our interpretation that endogenous modulation of klotho expression 
following injury can influence the course of muscle growth and regeneration. However, the 
time course of changes in expression that we describe differs from another report which 
stated that klotho expression in muscle is elevated at 3-days post-injury and then returns to 
baseline levels at 7-days post-injury. We cannot definitively explain the discrepancy, but we 
show that although klotho expression is reduced at 3-days, transcripts that specifically encode 
s-klotho are not reduced at that time. Because the primers used in the previous report (Sahu et
al., 2018) were not identified, we cannot address whether isoform specificity of the primers 
contributes to the discrepancy. However,  biological reasons may also contribute to the 
different time courses of klotho expression in the investigations. Although both the previous 
(Sahu et al., 2018) and present investigations use acute injury models, the previous 
investigation induced muscle damage by cardiotoxin (CTX) injection and our study used 
BaCl2 injection. An earlier investigation showed that the peak increase of satellite cell 
numbers was earlier and returned to levels similar to non-injured controls more rapidly in 
BaCl2 injured muscles than in CTX injuries (Hardy et al. 2016), indicating differences in the 
course and magnitude of muscle injury and repair in the two models.  The injury models also 
produce different inflammatory responses that are potentially important because we have 
found that klotho is primarily expressed in inflammatory lesions in acutely injured muscle. 
For example, CTX-induced muscle injuries cause extensive, prolonged neutrophilia while 
BaCl2-induced injuries cause prolonged elevations of macrophage numbers in injured muscle 
(Hardy et al., 2016). In addition, CTX can contain phospholipase A2 and can interact with 
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endogenous phospholipase A2 to affect the activation of numerous leukocyte populations, 
including neutrophils, mast cells and macrophages (Basanov, Dagda, & Rael, 2014; Gutierrez 
& Lomonte, 2004; Teixeira et al., 2003; Zuliani et al., 2005a, 2005b). Furthermore, in the 
previous investigation of klotho expression in CTX-injured muscle, mice were treated with 
non-steroidal anti-inflammatory drugs (NSAIDS) for 3 days following muscle injury, but 
NSAIDS were not administered in the present investigation. NSAIDS can increase numbers 
of M2-biased macrophages in injured muscle (Cheung and Tidball, 2003), which could affect 
magnitude and time course of changes in klotho expression. 
Our data show that elevations in klotho expression greatly accelerate muscle fiber growth at 
later stages of regeneration. In contrast to wild-type muscle fibers at 21-days post-injury that 
grew to obtain cross-sectional areas that were only 62% of uninjured controls (~ 1800 m
2
), 
klotho transgenic muscles returned to the size of uninjured fibers by 21-days post-injury (~ 
3000m
2
). This accelerated growth in klotho transgenic muscles may be partly attributable to 
direct actions of Klotho on myotubes and nascent muscle fibers, because previous findings 
show that direct stimulation of myotubes in vitro with Klotho shifts them to a positive protein 
balance (Wehling-Henricks et al., 2016). However, the positive influence on muscle fiber 
growth may also reflect an increase in MPC proliferation, as has been demonstrated in in 
vitro studies in which recombinant Klotho in the presence of its co-factors more than doubled 
the proportion of myoblasts that were Ki67+ (Wehling-Henricks et al., 2016). Previous 
investigators showed that the growth of muscle fibers may be influenced by the number of 
satellite cells present, at least in young animals (White et al., 2010), with larger numbers of 
satellite cells associated with greater muscle fiber growth.  Thus, the large increase in Pax7+ 
cells in klotho transgenic muscles at 7-days post-injury may contribute to the accelerated 
growth of muscle fibers in transgenic mice between 7- and 21-days post-injury.  
Indirect influences of the klotho transgene may also play a role in promoting muscle fiber 
growth. Our findings show that klotho transgene expression increased the levels of transcripts 
associated with both M1-biased and M2-biased macrophage phenotypic markers at 21-days 
post-injury, and previous findings showed that macrophages play a significant role in 
increasing muscle fiber growth following injuries caused by increased muscle loading 
(Tidball & Wehling-Henricks, 2007). Similarly, depleting CD11b+ cells from mice (Arnold 
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following CTX-mediated muscle injury (Perdiguero et al., 2011).  Although macrophages can 
contribute to muscle growth following injury or disease through multiple mechanisms, 
including by removal of cellular debris to facilitate repair (Collins & Grounds, 2001; Deng et 
al., 2012; Mitchell, McGeachie, & Grounds, 1992) and participating in revascularization of 
the injured tissue (Shireman et al., 2007), macrophages can also act directly on muscle fibers 
to increase growth. For example, insulin-like growth factor-1 (IGF1) is a potent anabolic 
agent that can act directly on muscle fibers (Barton-Davis, Shoturma & Sweeney, 1999; 
Musarò et al., 1999) and the targeted deletion of IGF1 in macrophages greatly reduced 
growth of muscle fibers for at least 5 days following acute injury (Tonkin et al., 2015). In 
addition, CD206+ macrophages are also rich sources of Klotho in dystrophic muscle in which 
they accumulate at sites of muscle fiber regeneration and growth, and increased expression of 
Klotho by macrophages increases muscle fiber growth (Wehling-Henricks et al., 2018). 
 
Other reports have shown relationships between perturbations in Klotho expression and 
satellite cell numbers and muscle size, although the observations collectively show that the 
effects on myogenesis caused by increased delivery of Klotho by a klotho transgene and by 
reduction of Klotho in hypomorphic mutant mice in non-injured muscles are not symmetrical. 
For example, data in the present investigation show that expression of the klotho transgene 
did not affect fiber size or numbers of satellite cells in mature, non-injured muscles. 
However, klotho mutation caused reductions of muscle fiber size (Ahrens et al., 2018; Iida et 
al., 2011), reductions in satellite cell numbers (Ahrens et al., 2018) and smaller muscle mass, 
at least in female mice (Phelps et al., 2013). Thus, the asymmetrical outcomes in non-injured 
muscles obtained by klotho overexpression and klotho mutation indicate that Klotho is 
essential for normal myogenesis, but supraphysiological levels do not further enhance 
myogenesis in healthy muscles. However, following muscle injury or disease, the effects of 
reduced Klotho production and increased Klotho production on muscle regeneration and 
growth are inverse. Elevation in klotho expression during muscle growth following acute 
injury or disease increases muscle fiber growth (Wehling-Henricks et al., 2016; present 
investigation), and klotho hypomorphic mutations reduce muscle regeneration following CTX 
injection (Ahrens et al., 2018).  
 
An intriguing and unexplained observation in our investigation is that elevation of klotho 
expression at 3-days post-injury is associated with reductions in Wnt-signaling, but Wnt 
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signaling is not reduced by the transgene at later stages of muscle growth and regeneration, 
although klotho expression levels are 263- to 836-fold higher than wild-type controls over the 
entire course of muscle repair that was assessed. A potential explanation for this restricted 
period of inhibited Wnt signaling in klotho transgenic muscles would be that Wnt signaling is 
more-strongly, negatively regulated through Klotho-independent pathways during later stages 
of myogenesis that follow acute injury. That speculation is supported by the large reductions 
in expression of the Wnt target genes Ccnd1 and Myc that occur between 3- and 7-days post-
injury in both wild-type and klotho transgenic muscles. Our data also suggest that the Klotho-
independent down regulation of Wnt signaling may be mediated by Axin2. Although Axin2 
is a Wnt target, it is also a negative regulator of Wnt signaling by promoting β-catenin 
degradation (Liu et al., 2007; Lustig et al., 2002). Thus, the elevation in Axin2 expression in 
both wild-type and klotho transgenic mice between 3- and 7-days post-injury may be 
sufficient to drive the large reductions in Ccnd1 and Myc that obscure a less potent inhibitory 
affect that is mediated by Klotho. 
5  CONCLUSIONS 
Our study shows that elevated expression of klotho can increase muscle growth and 
regeneration following acute muscle injuries in healthy, adult mice, and supports the 
possibility that increased delivery of Klotho could have therapeutic value for promoting 
repair of damaged muscle. This beneficial effect is not limited to acute muscle injuries 
because we previously demonstrated that elevated klotho expression improved regeneration, 
reduced fibrosis and improved function in muscular dystrophy (Wehling-Henricks et al., 
2016). However, these growth-promoting effects appear to be limited to injured or diseased 
muscles, because muscle fiber size and satellite cell numbers are not influenced by expression 
of the klotho transgene in mature, healthy muscle. As we pursue a better understanding of the 
regulatory influences of Klotho on skeletal muscle growth and adaptation, continuing studies 
are directed toward elucidating the Wnt-dependent and Wnt-independent pathways through 
which Klotho promotes repair of injured muscle.  
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Figure 1. Acute injury affected klotho expression in skeletal muscle. (A) QPCR data showing 
reduced klotho expression 3-days after sterile muscle injury and increased expression 7-days 
after injury of tibialis anterior (TA) muscle of 5-months old wild-type (Wt) mice. (B) QPCR 
data showing that s-klotho expression in muscle increased at 7- and 21-days following injury. 
(C) QPCR data showing that Fgf23 expression was not significantly affected by muscle 
injury. N = 5 per data set. * indicates significantly different from non-injured muscle, # 
indicates significantly different from muscle 3-days post-injury and ^ indicates significantly 
different from muscle 7-days post-injury at P < 0.05 analyzed by one-way ANOVA. Bars = 
standard deviation. (D-F) Serial sections of TA muscles of 5-months old mice at 7-days post-
injury that were immunolabeled for Klotho (D), CD206 (E) or Pax7 (F).  An inflammatory 
lesion surrounded by four muscle fibers (1-4) shows highest levels of Klotho (D; reddish-
brown), elevated numbers of CD206+ macrophages (E; reddish brown) and Pax7+ cells 
associated with the neighboring muscle fibers (arrows) (F). Bars = 50 μm. 
 
Figure 2. Klotho and Fgf23 expression in skeletal muscle of klotho transgenic mice after 
acute injury. (A) QPCR analysis of klotho expression shows a large increase in KL mRNA 
levels in KL+ non-injured and injured TA muscles relative to Wt non-injured TA muscle. (B) 
QPCR analysis reveals that the expression of a KL transgene does not significantly affect 
Fgf23 expression in healthy or injured muscle. N = 5 per data set. * indicates significantly 
different from non-injured Wt muscle.  indicates significantly different from non-injured 
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KL+ muscle, # indicates significantly different from KL+ muscle 3-days post-injury at P < 
0.05 
Figure 3. Expression of a klotho transgene reduced muscle mass but not muscle fiber size in 
non-injured adult TA muscle. Body mass (A), TA muscle mass (B) and the ratio of TA 
muscle mass normalized to body mass (C) was analyzed in 5-months old Wt and KL+ mice. 
N = 8 per data set. * indicates significantly different from Wt muscle at P < 0.05 analyzed by 
t test. TA muscle fiber cross-sectional area (D) was not affected by klotho transgene 
expression in 5-months old mice. N = 5 per data set. Representative images of cross sections 
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Figure 4. Expression of a klotho transgene improved muscle regeneration after acute injury. 
(A, B) Representative images of cross sections of TA muscles from Wt (A) and KL+ (B) 
mice 7-days post-injury stained with hematoxylin. The average cross-sectional area of fibers 
(C) and frequency distribution of fiber cross-sectional areas (D) for TA muscles from 5-
months old Wt and KL+ mice 7-days post-injury. (E, F) Hematoxylin stained representative 
images of cross sections of TA muscles from Wt (E) and KL+ (F) mice 21-days post-injury. 
(G) The average cross-sectional area of fibers of KL+ muscle 21-days post-injury were larger 
than Wt. (H) Frequency distribution of fiber cross-sectional areas for TA muscles from 5-
months old Wt and KL+ mice 21-days post-injury. N = 5 for each data set. * indicates 
significantly different from Wt muscle 21-days post-injury and # indicates a significant 
increase in the proportion of large muscle fibers of KL+ mice at P < 0.05 analyzed by t test. 
Large fibers (> 3094 μm
2
) are 3 standard deviations above the average cross-sectional area of 
Wt mice 21-days post-injury. Bars = 100 μm.  
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Figure 5. Expression of a klotho transgene affected myogenesis after acute injury. (A) Non-
injured, 3-, 7- and 21-days post-injury TA muscles from 5-months old Wt and KL+ mice 
were immunolabeled for Pax7. Klotho transgene expression increased the number of Pax7+ 
cells per volume at 7- and 21-days post-injury. Representative images of TA muscle cross 
sections from Wt (B) and KL+ (C) mice 7-days post-injury immunolabeled with anti-Pax7 
(reddish-brown nuclei). Fibers labelled with * are associated with multiple Pax7+ cells in a 
single plane of section. (D) TA muscle cross sections were also labeled with anti-MyoD. 
Injured muscle of KL+ mice showed an initial reduction in the number of MyoD+ cells per 
volume 3-days post-injury, which was followed by a subsequent increase in the density of 
MyoD+ cells 7-days post-injury. Representative images of Wt (E) and KL+ (F) TA muscle 
cross sections 7-days post-injury immunolabeled for MyoD (reddish-brown nuclei). (G) The 
expression of a klotho transgene increased the density of myogenin+ cells during the 
regenerative period 7-days post-injury and subsequently reduced the number of myogenin+ 
cells per volume 21-days post-injury relative to Wt. Photomicrographs of Wt (H) and KL+ (I) 
TA muscle cross sections labeled for myogenin (reddish-brown nuclei) 7-days post-injury. 
Data are expressed as the number of Pax7+, MyoD+ and myogenin+ cells per mm
3
. * in A, D 
and G indicates significantly different from non-injured muscle, # indicates significantly 
different from muscle 3-days post-injury and  indicates significantly different from muscle 
7-days post-injury within the same genotype at P < 0.05 analyzed by one-way ANOVA. 
indicates significantly different from Wt in the same treatment group at P < 0.05 analyzed 
by t test. N = 4-6 for each data set. Bars = 100 μm.
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Figure 6. Klotho treatment in the presence of FGF23 and heparin decreased the expression of 
myogenic transcription factors by MPCs in vitro. Myoblasts (A-C) or myotubes (D-F) were 
treated with heparin alone (Hep), Klotho and heparin (KL), FGF-23 and heparin (FGF23) or 
Klotho with FGF-23 and heparin (KL, FGF23). Stimulation with Klotho and its co-factors directly 
induced significant reductions in the expression of MyoD and myogenin in both myoblasts and 
myotubes. N = 5 replicates for each treatment condition. * indicates significant difference from 
heparin and # indicates significantly different from FGF23 by one-way ANOVA, P < 0.05.  
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Figure 7. Klotho transiently inhibited Wnt signaling in injured skeletal muscle. QPCR data 
showing relative expression for transcripts of Wnt signaling target genes axin2 (A), ccnd1(B) 
and myc (C) in TA muscle lysates of Wt and KL+ mice. * indicates significantly different 
from non-injured muscle and # indicates significantly different from muscle 3-days post-
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significantly different from Wt in same treatment group at P < 0.05 analyzed by t test. N = 5 
for each data set. (D) Immunofluorescent double labeling for Pax7 and active β-catenin in TA 
muscle cross sections 3-days post-injury demonstrated fewer Pax7+ cells expressing active β-
catenin indicating reduced Wnt signaling in satellite cells of KL+ muscle. * indicates 
significantly different from Wt muscle at P < 0.05 analyzed by t test. N = 5 for each data set. 
Sections of Wt (E-H) and KL+ (I-L) muscle 3-days after injury labeled with anti-Pax7 (red; 
E, I), anti-β-catenin (green; F, J), nuclei labeled with DAPI (blue; G, K) and the merged 
images (from left to right; H, L).  Bars = 25 μm. 
 
Figure 8. Klotho modulated the inflammatory response in muscle after injury. QPCR data 
showing relative expression of transcripts for the pan-macrophage marker F4/80 (A), M1-
biased macrophage marker Cd68 (B) or M2-biased macrophage markers Cd163 (C) and 
Cd206 (D), as well as the pro-inflammatory cytokine Tnf (E) and anti-inflammatory cytokine 
Il10 (F). * indicates significantly different from non-injured muscle at same genotype and # 
indicates significantly different from muscle 3-days post-injury within the same genotype at 
P < 0.05 analyzed by one-way ANOVA.  indicates significantly different from Wt under 
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Table 1: Primer sequences. 
Gene Forward Reverse 
Axin2 GACGCACTGACCGACGATTC CTGCGATGCATCTCTCTCTGG 
Ccnd1 CGAGGAGCTGCTGCAAATG GGGTTGGAAATGAACTTCACATC 
Cd68 CAAAGCTTCTGCTGTGGAAAT GACTGGTCACGGTTGCAAG 
Cd163 GCAAAAACTGGCAGTGGG GTCAAAATCACAGACGGAG 
Cd206 GGATTGTGGAGCAGATGGAAG CTTGAATGGAAATGCACAGAC 
F480 GATACAGCAATGCCAAGCAG CAGCACGAGGGAGACACTT 
Hagh CACCACTCACCACCACTGG ACACTGAGAGACCCCACCTG 
Il10 CAAGGAGCATTTGAATTCCC GGCCTTGTAGACACCTTGGTC 
Klotho GTCTCGGGAACCACCAAAAG CTATGCCACTCGAAACCGTC 
Myc CCCTATTTCATCTGCGACGAG GACGTAGCGACCGCAACATAG 
Myod GAGCGCATCTCCACAGACAG AAATCGCATTGGGGTTTGAG 
Myogenin CCAGTACATTGAGCGCCTAC ACCGAACTCCAGTGCATTGC 
Pax7 CTCAGTGAGTTCGATTAGCCG AGACGGTTCCCTTTGTCGC 
Rnsp1 AGGCTCACCAGGAATGTGAC CTTGGCCATCAATTTGTCCT 
S-Klotho CAATGGCTTTCCTCCTTTACC GAGGCCGACACTGGGTTTTG 
Srp14 AGAGCGAGCAGTTCCTGAC CGGTGCTGATCTTCCTTTTC 
Tnf CTTCTGTCTACTGAACTTCGGG CACTTGGTGGTTTGCTACGAC 
